Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.63+0.51 (+8.33%)
Close on Nov 12, 2026Market cap $99.34MP/E –Yield –
Cumberland Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cumberland Pharmaceuticals's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $5.10M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $5.10M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | -100.0% |
| FY2010 | Dec 31, 2010 | $2.67M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $5.10M | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
See a number that looks wrong?